| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| Domain | CAPS | 1.42e-05 | 2 | 71 | 2 | IPR033227 | |
| Domain | DUF1041 | 1.41e-04 | 5 | 71 | 2 | SM01145 | |
| Domain | HELP | 2.12e-04 | 6 | 71 | 2 | PF03451 | |
| Domain | HELP | 2.12e-04 | 6 | 71 | 2 | IPR005108 | |
| Domain | DUF1041 | 2.96e-04 | 7 | 71 | 2 | PF06292 | |
| Domain | Munc13_1 | 2.96e-04 | 7 | 71 | 2 | IPR014770 | |
| Domain | CAPS_dom | 2.96e-04 | 7 | 71 | 2 | IPR010439 | |
| Domain | MHD1 | 2.96e-04 | 7 | 71 | 2 | PS51258 | |
| Domain | MARCH-like | 3.93e-04 | 8 | 71 | 2 | IPR033275 | |
| Domain | LDLR_class-A_CS | 4.70e-04 | 40 | 71 | 3 | IPR023415 | |
| Domain | Ldl_recept_a | 6.66e-04 | 45 | 71 | 3 | PF00057 | |
| Domain | - | 7.11e-04 | 46 | 71 | 3 | 4.10.400.10 | |
| Domain | RINGv | 7.66e-04 | 11 | 71 | 2 | PF12906 | |
| Domain | ZF_RING_CH | 7.66e-04 | 11 | 71 | 2 | PS51292 | |
| Domain | LDLRA_1 | 8.05e-04 | 48 | 71 | 3 | PS01209 | |
| Domain | - | 8.05e-04 | 48 | 71 | 3 | 2.120.10.80 | |
| Domain | CUB | 8.56e-04 | 49 | 71 | 3 | PF00431 | |
| Domain | LDLRA_2 | 8.56e-04 | 49 | 71 | 3 | PS50068 | |
| Domain | LDrepeatLR_classA_rpt | 8.56e-04 | 49 | 71 | 3 | IPR002172 | |
| Domain | LDLa | 8.56e-04 | 49 | 71 | 3 | SM00192 | |
| Domain | CUB | 9.08e-04 | 50 | 71 | 3 | SM00042 | |
| Domain | Quinoprot_gluc/sorb_DH | 9.18e-04 | 12 | 71 | 2 | IPR011041 | |
| Domain | - | 1.02e-03 | 52 | 71 | 3 | 2.60.120.290 | |
| Domain | CUB | 1.08e-03 | 53 | 71 | 3 | PS01180 | |
| Domain | Kelch-typ_b-propeller | 1.20e-03 | 55 | 71 | 3 | IPR015915 | |
| Domain | EGF_CA | 1.20e-03 | 122 | 71 | 4 | SM00179 | |
| Domain | EGF-like_Ca-bd_dom | 1.28e-03 | 124 | 71 | 4 | IPR001881 | |
| Domain | CUB_dom | 1.33e-03 | 57 | 71 | 3 | IPR000859 | |
| Domain | VWD | 1.65e-03 | 16 | 71 | 2 | SM00216 | |
| Domain | VWF_type-D | 1.65e-03 | 16 | 71 | 2 | IPR001846 | |
| Domain | MAM_1 | 1.65e-03 | 16 | 71 | 2 | PS00740 | |
| Domain | VWFD | 1.65e-03 | 16 | 71 | 2 | PS51233 | |
| Domain | VWD | 1.65e-03 | 16 | 71 | 2 | PF00094 | |
| Domain | Znf_RING-CH | 1.87e-03 | 17 | 71 | 2 | IPR011016 | |
| Domain | RINGv | 1.87e-03 | 17 | 71 | 2 | SM00744 | |
| Domain | MAM | 1.87e-03 | 17 | 71 | 2 | SM00137 | |
| Domain | MAM | 2.10e-03 | 18 | 71 | 2 | PF00629 | |
| Domain | G_crystallin-rel | 2.10e-03 | 18 | 71 | 2 | IPR011024 | |
| Domain | MAM_dom | 2.10e-03 | 18 | 71 | 2 | IPR000998 | |
| Domain | MAM_2 | 2.10e-03 | 18 | 71 | 2 | PS50060 | |
| Domain | Kelch_1 | 2.40e-03 | 70 | 71 | 3 | PF01344 | |
| Domain | Kelch_1 | 2.40e-03 | 70 | 71 | 3 | IPR006652 | |
| Domain | WD_REPEATS_1 | 4.12e-03 | 278 | 71 | 5 | PS00678 | |
| Domain | WD_REPEATS_2 | 4.19e-03 | 279 | 71 | 5 | PS50082 | |
| Domain | WD_REPEATS_REGION | 4.19e-03 | 279 | 71 | 5 | PS50294 | |
| Domain | HECT | 4.70e-03 | 27 | 71 | 2 | PF00632 | |
| Domain | HECTc | 4.70e-03 | 27 | 71 | 2 | SM00119 | |
| Domain | HECT_dom | 4.70e-03 | 27 | 71 | 2 | IPR000569 | |
| Domain | HECT | 4.70e-03 | 27 | 71 | 2 | PS50237 | |
| Domain | EGF_LAM_2 | 5.79e-03 | 30 | 71 | 2 | PS50027 | |
| Domain | EGF_LAM_1 | 5.79e-03 | 30 | 71 | 2 | PS01248 | |
| Domain | ASX_HYDROXYL | 6.54e-03 | 100 | 71 | 3 | PS00010 | |
| Pubmed | 8.68e-07 | 9 | 77 | 3 | 9693030 | ||
| Pubmed | COG2 HEATR6 ANK3 SBNO1 CADPS RBL2 GEMIN8 LRP4 KCNQ2 CIPC ZNF227 CADPS2 HECTD1 | 4.59e-06 | 1285 | 77 | 13 | 35914814 | |
| Pubmed | MARCH-III Is a novel component of endosomes with properties similar to those of MARCH-II. | 4.84e-06 | 2 | 77 | 2 | 16428329 | |
| Pubmed | 4.84e-06 | 2 | 77 | 2 | 18177725 | ||
| Pubmed | CAPS-1 and CAPS-2 are essential synaptic vesicle priming proteins. | 4.84e-06 | 2 | 77 | 2 | 18022372 | |
| Pubmed | CAPS facilitates filling of the rapidly releasable pool of large dense-core vesicles. | 4.84e-06 | 2 | 77 | 2 | 18495893 | |
| Pubmed | 4.84e-06 | 2 | 77 | 2 | 35982175 | ||
| Pubmed | 4.84e-06 | 2 | 77 | 2 | 28883501 | ||
| Pubmed | 4.84e-06 | 2 | 77 | 2 | 25719439 | ||
| Pubmed | Two distinct secretory vesicle-priming steps in adrenal chromaffin cells. | 4.84e-06 | 2 | 77 | 2 | 20855507 | |
| Pubmed | 1.45e-05 | 3 | 77 | 2 | 12659812 | ||
| Pubmed | An Alternative Exon of CAPS2 Influences Catecholamine Loading into LDCVs of Chromaffin Cells. | 1.45e-05 | 3 | 77 | 2 | 30389842 | |
| Pubmed | 1.45e-05 | 3 | 77 | 2 | 14530279 | ||
| Pubmed | Secretory vesicle priming by CAPS is independent of its SNARE-binding MUN domain. | 1.45e-05 | 3 | 77 | 2 | 25437547 | |
| Pubmed | Ca2+-dependent activator proteins of secretion promote vesicular monoamine uptake. | 1.45e-05 | 3 | 77 | 2 | 19008227 | |
| Pubmed | 1.45e-05 | 3 | 77 | 2 | 14762142 | ||
| Pubmed | Immunoglobulin genes of different subgroups are interdigitated within the VK locus. | 1.45e-05 | 3 | 77 | 2 | 6440122 | |
| Pubmed | Biological, clinical and population relevance of 95 loci for blood lipids. | 1.89e-05 | 146 | 77 | 5 | 20686565 | |
| Pubmed | 2.89e-05 | 4 | 77 | 2 | 6264318 | ||
| Pubmed | 2.89e-05 | 4 | 77 | 2 | 19238500 | ||
| Pubmed | Phosphatidylinositol 4,5-bisphosphate optical uncaging potentiates exocytosis. | 2.89e-05 | 4 | 77 | 2 | 29068313 | |
| Pubmed | 2.89e-05 | 4 | 77 | 2 | 16525039 | ||
| Pubmed | 4.82e-05 | 5 | 77 | 2 | 22111578 | ||
| Pubmed | 4.82e-05 | 5 | 77 | 2 | 25998125 | ||
| Pubmed | Munc13-1 and Munc18-1 together prevent NSF-dependent de-priming of synaptic vesicles. | 7.22e-05 | 6 | 77 | 2 | 28635948 | |
| Pubmed | Discovery and refinement of loci associated with lipid levels. | 1.09e-04 | 211 | 77 | 5 | 24097068 | |
| Pubmed | 1.34e-04 | 8 | 77 | 2 | 16506193 | ||
| Pubmed | Unconventional molecular regulation of synaptic vesicle replenishment in cochlear inner hair cells. | 1.34e-04 | 8 | 77 | 2 | 25609709 | |
| Pubmed | 2.04e-04 | 130 | 77 | 4 | 12421765 | ||
| Pubmed | CAPS1 regulates catecholamine loading of large dense-core vesicles. | 2.15e-04 | 10 | 77 | 2 | 15820695 | |
| Pubmed | The secretory granule-associated protein CAPS2 regulates neurotrophin release and cell survival. | 2.15e-04 | 10 | 77 | 2 | 14715936 | |
| Pubmed | SNARE protein recycling by αSNAP and βSNAP supports synaptic vesicle priming. | 2.15e-04 | 10 | 77 | 2 | 21040848 | |
| Pubmed | The morphological and molecular nature of synaptic vesicle priming at presynaptic active zones. | 2.63e-04 | 11 | 77 | 2 | 25374362 | |
| Pubmed | 5.28e-04 | 167 | 77 | 4 | 25659891 | ||
| Pubmed | 5.69e-04 | 16 | 77 | 2 | 14722266 | ||
| Pubmed | 6.44e-04 | 17 | 77 | 2 | 8223863 | ||
| Pubmed | 6.80e-04 | 1327 | 77 | 10 | 32694731 | ||
| Pubmed | 7.23e-04 | 18 | 77 | 2 | 37321992 | ||
| Pubmed | 7.23e-04 | 18 | 77 | 2 | 20399194 | ||
| Pubmed | 8.96e-04 | 20 | 77 | 2 | 10427970 | ||
| Pubmed | 8.96e-04 | 20 | 77 | 2 | 12743021 | ||
| Pubmed | 9.04e-04 | 85 | 77 | 3 | 23055939 | ||
| Pubmed | A systematic survey of carbonic anhydrase mRNA expression during mammalian inner ear development. | 1.09e-03 | 22 | 77 | 2 | 23233153 | |
| Pubmed | ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1. | 1.33e-03 | 1201 | 77 | 9 | 35696571 | |
| Pubmed | System-Wide Modulation of HECT E3 Ligases with Selective Ubiquitin Variant Probes. | 1.52e-03 | 26 | 77 | 2 | 26949039 | |
| Pubmed | 1.60e-03 | 225 | 77 | 4 | 12168954 | ||
| Pubmed | Large-scale proteomics and phosphoproteomics of urinary exosomes. | 1.83e-03 | 1016 | 77 | 8 | 19056867 | |
| Pubmed | 2.08e-03 | 242 | 77 | 4 | 34011540 | ||
| Interaction | ZBBX interactions | 4.14e-06 | 31 | 71 | 4 | int:ZBBX | |
| Cytoband | 2p12 | 4.70e-05 | 117 | 77 | 4 | 2p12 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr19q13 | 1.73e-04 | 1192 | 77 | 9 | chr19q13 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr2p11 | 4.68e-04 | 213 | 77 | 4 | chr2p11 | |
| GeneFamily | Immunoglobulin kappa locus at 2p11.2 | 1.02e-04 | 83 | 53 | 4 | 351 | |
| GeneFamily | Ring finger proteins|Membrane associated ring-CH-type fingers | 4.56e-04 | 11 | 53 | 2 | 60 | |
| Coexpression | HOLLEMAN_PREDNISOLONE_RESISTANCE_ALL_DN | 3.65e-06 | 11 | 75 | 3 | M2560 | |
| Coexpression | GSE29618_PRE_VS_DAY7_POST_LAIV_FLU_VACCINE_MDC_UP | 2.25e-05 | 198 | 75 | 6 | M5007 | |
| ToppCell | 10x_3'_v3-thymus_(10x_3'_v3)-lymphocytic-T_lymphocytic-CD4-positive_helper_T_cell|thymus_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.23e-06 | 198 | 77 | 6 | c4d8d133e571ad3a7c5de93aa7befb67cb7a003d | |
| ToppCell | mild_COVID-19_(asymptomatic)-CD4+_T_naive|World / disease group, cell group and cell class (v2) | 7.83e-06 | 157 | 77 | 5 | 23879e65a6acc33d9aad096cd23604a77b0ac9c2 | |
| ToppCell | severe_influenza-CD4+_T_naive|World / disease group, cell group and cell class (v2) | 8.08e-06 | 158 | 77 | 5 | 8ab3d8a9b7a1daa890d76dde1d6182af40b70021 | |
| ToppCell | Severe-Lymphoid-NK-CCR7+_T|Severe / Condition, Lineage, Cell class and cell subclass | 9.39e-06 | 163 | 77 | 5 | 8f0d8c124f1569a5a6bc1db7581989f24d63cca3 | |
| ToppCell | Control-Lymphoid-B_Plasma|Control / Disease state, Lineage and Cell class | 1.22e-05 | 172 | 77 | 5 | 61e33836b8cb0f347f3e699eb587a37073b6fa4c | |
| ToppCell | 3'_v3-bone_marrow-Lymphocytic_B_plasma-Plasma_cells|bone_marrow / Manually curated celltypes from each tissue | 1.32e-05 | 175 | 77 | 5 | 51301f3f44d3e88397f367cedd1e2abaa2be4c6f | |
| ToppCell | Control-Lymphocyte-T_NK-CD8_TCM|Control / Disease, Lineage and Cell Type | 1.36e-05 | 176 | 77 | 5 | 1a7948eb86ee1da607db4d0576312b2859d94523 | |
| ToppCell | facs-Pancreas-Exocrine-3m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.44e-05 | 178 | 77 | 5 | fcbbcc44271515de1969b4732b6441c012693d5f | |
| ToppCell | COVID-CD4-naive_CD4|COVID / Condition, Cell_class and T cell subcluster | 1.69e-05 | 184 | 77 | 5 | 00db55970d336a301035efe43a4ab4db62627f38 | |
| ToppCell | droplet-Fat-SCAT-30m-Epithelial|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.82e-05 | 187 | 77 | 5 | 5fada3c5a58c1890029ccbfff2608b33f8cd2df7 | |
| ToppCell | droplet-Fat-SCAT-30m-Epithelial-nan|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.82e-05 | 187 | 77 | 5 | 766e808138fc2cd623c2e6d57fcb5c7378da0e03 | |
| ToppCell | Smart-seq2-lymph_node_(Smart-seq2)-lymphocytic-T_lymphocytic-effector_CD4-positive,_alpha-beta_T_cell|lymph_node_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.82e-05 | 187 | 77 | 5 | e61c1755531469dd3850c9740474b5ad4e0499c1 | |
| ToppCell | droplet-Fat-SCAT-30m-Epithelial-epithelial_cell|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.82e-05 | 187 | 77 | 5 | f49d06600060deeb2fc1b1da5b93496535f20104 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c03-ITGA4|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.97e-05 | 190 | 77 | 5 | 91ba66d4b56c59523485b17738e93f14bb00afa4 | |
| ToppCell | COVID-19_Moderate-CD4+_T_activated|World / disease group, cell group and cell class | 2.12e-05 | 193 | 77 | 5 | c2a2a2c14a7085690262db5c2a70e38db67dee18 | |
| ToppCell | COVID_non-vent-Lymphocytic-T_cell|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 2.23e-05 | 195 | 77 | 5 | 4bdedd924564a260841a9153604026b57487c83d | |
| ToppCell | mild_COVID-19_(asymptomatic)-CD4+_Tcm|World / disease group, cell group and cell class (v2) | 2.23e-05 | 195 | 77 | 5 | a72bb5b1b15dd1ab70ced5622d94499caff8bb6b | |
| ToppCell | Bronchial-NucSeq|Bronchial / Cell types per location group and 10X technology with lineage, and cell group designations | 2.28e-05 | 196 | 77 | 5 | ab53c742866945545a92e2e61850d63c80d9a2a6 | |
| ToppCell | Severe_COVID-19-T/NK-CD4+_T_1|Severe_COVID-19 / Disease group,lineage and cell class (2021.01.30) | 2.40e-05 | 198 | 77 | 5 | bc6b983fdb9547ef8a9e693bc15fced1b73e101f | |
| ToppCell | BAL-Severe-Lymphocyte-T/NK-CD4+_T-CD4+_T-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.40e-05 | 198 | 77 | 5 | fc8099bce80d84b29bdcc87064d4d8375dddfa0f | |
| ToppCell | BAL-Severe-Lymphocyte-T/NK-CD4+_T-CD4+_T_1|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 2.40e-05 | 198 | 77 | 5 | 32ec322ed144c545014b191da5274d12feeaf96b | |
| ToppCell | COVID_vent-Lymphocytic-T_cell-CD4+_Memory_T_cell|COVID_vent / Disease condition, Lineage, Cell class and subclass | 2.40e-05 | 198 | 77 | 5 | 58f208b76cb0adcecdf632d92f92833a06f9bf71 | |
| ToppCell | 10x_3'_v3-thymus_(10x_3'_v3)-lymphocytic-T_lymphocytic|thymus_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.40e-05 | 198 | 77 | 5 | db107a5511571384f26e26c6301aef9a9f2423c4 | |
| ToppCell | BAL-Severe-Lymphocyte-T/NK-CD4+_T-CD4+_T_1-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 2.40e-05 | 198 | 77 | 5 | 1e281d8f0291e8cf814e9e5abd7f5860402a7c77 | |
| ToppCell | BAL-Severe-Lymphocyte-T/NK-CD4+_T-CD4+_T|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.40e-05 | 198 | 77 | 5 | 74f190d8e337cff5ffb65d446cf784759e1c2a59 | |
| ToppCell | VE-CD4-antiviral_CD4|VE / Condition, Cell_class and T cell subcluster | 2.46e-05 | 199 | 77 | 5 | 056a0538ca5e825ae6195b4c76c208708a014533 | |
| ToppCell | 10x5'-Lung-Lymphocytic_T_CD4-Teffector/EM_CD4|Lung / Manually curated celltypes from each tissue | 2.46e-05 | 199 | 77 | 5 | 54b6a43e23826d507b8f1db578e589711d49bbfd | |
| ToppCell | droplet-Marrow-nan-21m-Lymphocytic-immature_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.42e-05 | 119 | 77 | 4 | aa3860c8d25c85baa79a0b6637bce2e269adfcc2 | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_2-Differentiating_AT1|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.99e-05 | 127 | 77 | 4 | 5b0adbcafad31a6759c9bdce2f7f9591a8edc450 | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-1M-Radial_glial-RGCs_3|Organoid-1M / Sample Type, Dataset, Time_group, and Cell type. | 9.11e-05 | 136 | 77 | 4 | 5e209185b5f6e9347829fc9066f0b2c3711df057 | |
| ToppCell | 3'_v3-Lung-Lymphocytic_T_CD4-Tfh|Lung / Manually curated celltypes from each tissue | 1.08e-04 | 142 | 77 | 4 | 319812c84fad93276bf093f2ad78db02ae745bf4 | |
| ToppCell | Influenza_Severe-CD4+_T_naive|World / Disease group and Cell class | 1.30e-04 | 149 | 77 | 4 | ce6552063510aa3e0b9d6e5b531eea67410e7056 | |
| ToppCell | normal-na-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-male|normal / PBMC cell types (v2) per disease, treatment status, and sex | 1.51e-04 | 155 | 77 | 4 | 08295584395e8d9cfc1b1648f98754b3ac53e587 | |
| ToppCell | Adult-Immune-mast_cell-D231|Adult / Lineage, Cell type, age group and donor | 1.58e-04 | 157 | 77 | 4 | 4c63bb91f8708644e6ce2500072a4eeb8e1079dd | |
| ToppCell | Influenza_Severe-CD4+_T_naive|Influenza_Severe / Disease group and Cell class | 1.58e-04 | 157 | 77 | 4 | 287bdc4e455cd0160261a93d13538e0def49fcd4 | |
| ToppCell | 368C-Myeloid-Dendritic-cDC1|368C / Donor, Lineage, Cell class and subclass (all cells) | 1.62e-04 | 158 | 77 | 4 | c276a259e20ee704e2d04baf693e8d677f96f654 | |
| ToppCell | severe_influenza-CD4+_T_naive|severe_influenza / disease group, cell group and cell class (v2) | 1.62e-04 | 158 | 77 | 4 | ff3fa4bd06e01363429aec4bb587b95819bf0fc9 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Lymphoid-CD4/CD8-CD8_NK_sig-Z|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.66e-04 | 159 | 77 | 4 | bf8ff9251bcb64b2b9d6dd93461aec97659686ec | |
| ToppCell | COVID-CD4-CD4_Treg|COVID / Condition, Cell_class and T cell subcluster | 1.66e-04 | 159 | 77 | 4 | 037cd97c41eb2f91fd3f69bbb3ffdfd6c0158410 | |
| ToppCell | 356C-Myeloid-Macrophage-SPP1+_Macrophage|356C / Donor, Lineage, Cell class and subclass (all cells) | 1.79e-04 | 162 | 77 | 4 | 2f19539c455d1e5d514725845234c7547020e6ad | |
| ToppCell | 10x5'-GI_large-bowel-Lymphocytic_T_CD4-Tfh|GI_large-bowel / Manually curated celltypes from each tissue | 1.83e-04 | 163 | 77 | 4 | 4104d3b9748b39cb0744c9be76db21bdda566a0d | |
| ToppCell | LPS_only-Epithelial_airway-Club_cells-Airway|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.87e-04 | 164 | 77 | 4 | b1243b10591e1e15a94952e39ffbf382eae6aae8 | |
| ToppCell | 3'_v3-Lung-Lymphocytic_B_plasma-Plasma_cells|Lung / Manually curated celltypes from each tissue | 1.87e-04 | 164 | 77 | 4 | 3b6a32ba53d05f6818fe950ac426f489383b645a | |
| ToppCell | LPS_only-Epithelial_airway-Club_cells|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.87e-04 | 164 | 77 | 4 | c5b2001280a43da855017361a3f6071a0e492848 | |
| ToppCell | LPS_only-Epithelial_airway|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.87e-04 | 164 | 77 | 4 | 56e6934e6c7503a300d7be06762d45a1d6f1ae0f | |
| ToppCell | LPS-antiTNF-Epithelial_airway-Club_cells|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.96e-04 | 166 | 77 | 4 | 1df4bdf7c773cbfa6c93d7a901f9cd3f3fe07a3d | |
| ToppCell | LPS-antiTNF-Epithelial_airway-Club_cells-Airway|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.96e-04 | 166 | 77 | 4 | 9628522e7af8f8edca733588a364ab2454ac5ca5 | |
| ToppCell | BAL-Severe-cDC_2|Severe / Compartment, Disease Groups and Clusters | 1.96e-04 | 166 | 77 | 4 | 602a72a607534d5f21eddd2c7a52a57084f4920f | |
| ToppCell | mild_COVID-19_(asymptomatic)-CD4+_T_naive|mild_COVID-19_(asymptomatic) / disease group, cell group and cell class (v2) | 2.01e-04 | 167 | 77 | 4 | 78d264af390bd89942ffbb2991dc94f50756d4c9 | |
| ToppCell | 10x5'-GI_large-bowel|World / Manually curated celltypes from each tissue | 2.05e-04 | 168 | 77 | 4 | 1290c909655bc37f6b8bf216d18127a21b99e9c0 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_airway-Club_cells|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.10e-04 | 169 | 77 | 4 | 8c96e1baa38ec5e777e627ab9dbce025e771f2c0 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_airway-Club_cells-Airway|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.10e-04 | 169 | 77 | 4 | 86041be5d3aeab5b9269f7912791b944f325a1b4 | |
| ToppCell | droplet-Thymus-nan-18m-Myeloid-Macrophage|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.10e-04 | 169 | 77 | 4 | 4ac21e8199de4b6917eacadc56fffc6d886ee643 | |
| ToppCell | Control-Lymphoid-B_Plasma|World / Disease state, Lineage and Cell class | 2.15e-04 | 170 | 77 | 4 | fb05f49b7113470995b3c16683c54dc1a660b73a | |
| ToppCell | 356C-Myeloid-Dendritic-cDC_proliferating_2|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 2.20e-04 | 171 | 77 | 4 | b113fbebb89056af0b9c775d2fb6552206a80467 | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Epithelial-epithelial_progenitor_cell-Distal_progenitor|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.30e-04 | 173 | 77 | 4 | 81c36b9fe02c59099f080b2db02f4eaf2783911f | |
| ToppCell | droplet-Marrow-nan-18m-Myeloid-basophil|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.35e-04 | 174 | 77 | 4 | 55cc8300489d11322724159ec7d0e1d32a702e91 | |
| ToppCell | 390C-Lymphocytic-CD4_T-cell-CD4+_Effector_T_cell-1|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 2.40e-04 | 175 | 77 | 4 | 6374ab186d7ccf7f6dfb858267edba8962789e15 | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.61e-04 | 179 | 77 | 4 | fd2cbee532e7b44113410dca82aec7db1a7fb69f | |
| ToppCell | droplet-Fat-Gat-18m-Endothelial-nan|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.61e-04 | 179 | 77 | 4 | 08cf9986804a6417a9afb19b50c69a3554f71ec6 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Hematopoietic-T_cells-Treg|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.73e-04 | 181 | 77 | 4 | 3754970d62eea1d2522b11d977eea4362f90d21e | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c06-NR4A2|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.78e-04 | 182 | 77 | 4 | 9ba85f621a846531a2a7861e9df695d288c9e149 | |
| ToppCell | COPD-Myeloid-Mast|World / Disease state, Lineage and Cell class | 2.78e-04 | 182 | 77 | 4 | 68a1e7b804f309bfd6c23d65fad20a9a962712ae | |
| ToppCell | wk_20-22-Hematologic-Myeloid-Basophil|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 2.84e-04 | 183 | 77 | 4 | 93d821d5340caed0eef455d3d738be213ce5fff8 | |
| ToppCell | 10x3'2.3-week_17-19-Mesenchymal_osteo-stroma-early_osteoblast|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 2.84e-04 | 183 | 77 | 4 | 27a57cd8ea924420e182f3d72f5b29b00dea8fa0 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c01-LEF1|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.84e-04 | 183 | 77 | 4 | f2ef110bf29b1a8276ef216238363e542db262c1 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.90e-04 | 184 | 77 | 4 | 102105ae1a5ef6d42a43f6d9b00f12ed0690ddb7 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c01-LEF1|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.90e-04 | 184 | 77 | 4 | 5350b58aa9979631228835d11eb45ddf81d08bff | |
| ToppCell | facs-Lung-24m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l17|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.90e-04 | 184 | 77 | 4 | d754c3de621429b220ae4ac426cdfc619e848462 | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.90e-04 | 184 | 77 | 4 | ab2f06906fc7a9931dfa0864ef506832b07fb93e | |
| ToppCell | droplet-Limb_Muscle-nan-18m-Macroglial-unknown|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.90e-04 | 184 | 77 | 4 | a7399a72f065d68800e3e0b2031d9894e0cc0ba4 | |
| ToppCell | systemic_lupus_erythematosus-treated-Lymphocytic_T-CD4-positive,_alpha-beta_T_cell-female|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 2.96e-04 | 185 | 77 | 4 | 406b52516b26e9fe2c9e768950af447ec7ad5f3e | |
| ToppCell | Control-Epithelial_alveolar-AT_2-Differentiating_AT2|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.96e-04 | 185 | 77 | 4 | 0d2add28ac1f4fa6de7699be009bf8391badaf4c | |
| ToppCell | droplet-Liver-LIVER_HEP-30m-Mesenchymal|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.96e-04 | 185 | 77 | 4 | f814ec9d4ade717a0109398e9768d0d66f09317b | |
| ToppCell | droplet-Liver-LIVER_HEP-30m-Mesenchymal-hepatic_stellate_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.96e-04 | 185 | 77 | 4 | 40e958511790e84321da5ccf735f9974c06a0263 | |
| ToppCell | droplet-Liver-LIVER_HEP-30m-Mesenchymal-hepatic_stellate_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.96e-04 | 185 | 77 | 4 | 5f2eeba80aff145e85cfd81e2890a155406badb9 | |
| ToppCell | systemic_lupus_erythematosus-treated-Lymphocytic_T-CD4-positive,_alpha-beta_T_cell|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 2.96e-04 | 185 | 77 | 4 | f2ebd099c8dfcfaca4298bcdd618c50701a9c2c8 | |
| ToppCell | Control-Lymphoid-B_Plasma|Lymphoid / Disease state, Lineage and Cell class | 3.02e-04 | 186 | 77 | 4 | a08a50bff4e629588faa22440d57334b1df0e8df | |
| ToppCell | 5'-Parenchyma_lung-Immune_Myeloid_mast-Myeloid_Mast/Baso-mast_cell-Mast_cells|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.09e-04 | 187 | 77 | 4 | bdcef4f3e093c3646b639a189bbe93d6f4c40f3c | |
| ToppCell | 5'-Parenchyma_lung-Immune_Myeloid_mast-Myeloid_Mast/Baso-mast_cell|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.09e-04 | 187 | 77 | 4 | 09348f1e8bbbca8dca885461937b9b1dd248b034 | |
| ToppCell | 5'-Parenchyma_lung-Immune_Myeloid_mast|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.09e-04 | 187 | 77 | 4 | 0f7a42c55997e34a0d20e492e16b03e91e965335 | |
| ToppCell | 5'-Parenchyma_lung-Immune_Myeloid_mast-Myeloid_Mast/Baso|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.09e-04 | 187 | 77 | 4 | 064730fa72f8637c3db3fc34d2e363d2b9a38f1d | |
| ToppCell | Control-Lymphocyte-T_NK-CD4_TCM|Control / Disease, Lineage and Cell Type | 3.09e-04 | 187 | 77 | 4 | 1de80f40f753b31aed1fac9f3ff8a2ee6c755eec | |
| ToppCell | (1)_T_CD4_naive|World / Spleen cell shreds - cell class (v1) and cell subclass (v1) | 3.15e-04 | 188 | 77 | 4 | b8f67ac2faadd5b848955e43ab5d6cf5e49b3681 | |
| ToppCell | severe_influenza-CD4+_Tcm|severe_influenza / disease group, cell group and cell class (v2) | 3.15e-04 | 188 | 77 | 4 | 633e5545f49b1b864b0ffa5fc9688d270690f884 | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Hematopoietic-T_cells-SELL+_CD8_T|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.15e-04 | 188 | 77 | 4 | a2f42a86418a52cd12c3a699ab290d7d86826359 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.21e-04 | 189 | 77 | 4 | 9ab77c6fcb573854da5922412f53d2168bda6b58 | |
| ToppCell | Bac-SEP-Lymphocyte-T_NK-CD4_TCM|Bac-SEP / Disease, Lineage and Cell Type | 3.21e-04 | 189 | 77 | 4 | 70f918dc208cd7ce8de9007729d8c5743c56c130 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c06-NR4A2|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.21e-04 | 189 | 77 | 4 | 8130102c41b2978a8b83f765ce383f836a464795 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.21e-04 | 189 | 77 | 4 | 5a9e2ca9a9ee2dc37ab9147a902115a9f1a80169 | |
| ToppCell | 10x3'2.3-week_12-13-Mesenchymal_fibro-stroma-endosteal_fibroblast|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 3.21e-04 | 189 | 77 | 4 | c392491aabe8a3e90974ab2ea123bbbe5200439d | |
| ToppCell | 5'-Parenchyma_lung-Immune_Myeloid_mast-Myeloid_Mast/Baso-mast_cell-Mast_cells-Mast_cells_L.1.4.3.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.21e-04 | 189 | 77 | 4 | f01158bb15df3117fae1271bf8cf8c2501422671 | |
| ToppCell | renal_medulla_nuclei|World / Celltypes from Cells and Nuclei per compartment and clinical group | 3.21e-04 | 189 | 77 | 4 | 830d9cd0dd706bce22eb2416f07b2c31c870a05a | |
| ToppCell | Leuk-UTI-Lymphocyte-T_NK-CD4_TCM|Leuk-UTI / Disease, Lineage and Cell Type | 3.28e-04 | 190 | 77 | 4 | 5f8d606d2f465ddeae7451835f84b3f25a151d2a | |
| ToppCell | Fetal_29-31_weeks-Immune-T_lymphocyte-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.28e-04 | 190 | 77 | 4 | 2a8de1cf27a9ebc3825cf9e7a489ecd064dfc7f9 | |
| ToppCell | 10x_3'_v3-tissue-resident_(10x_3'_v3)-myeloid-myeloid_granulocytic-mast_cell|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 3.28e-04 | 190 | 77 | 4 | 7774dc0b4ae7d5920b516800f3b90cbf831f8d3d | |
| ToppCell | droplet-Liver-hepatocytes-3m-Epithelial-duct_epithelial_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.28e-04 | 190 | 77 | 4 | 5b3f773380aef4773b70f0dbd74992d28e6586c6 | |
| ToppCell | ASK428-Immune-NK_cell|Immune / Donor, Lineage and Cell class of Lung cells from Dropseq | 3.28e-04 | 190 | 77 | 4 | d649f7e17c4227787465dfc02037f791ff85378b | |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic_T-T4_em-male|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 3.28e-04 | 190 | 77 | 4 | f6616b3fe7f4962249503c96c06926240066d861 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_adventitial_fibro_(10)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 3.28e-04 | 190 | 77 | 4 | 4f775ee24b14733f06ae40b45f2dc1a0f0df0705 | |
| Disease | Chromosome 2q37 deletion syndrome | 3.32e-05 | 4 | 70 | 2 | C2931817 | |
| Disease | waist-hip ratio | ANK3 MEGF8 ADAMTS2 CADPS RBL2 DSTYK SYNE2 MC4R KIAA1328 ABHD17C CDON | 1.39e-04 | 1226 | 70 | 11 | EFO_0004343 |
| Disease | triglycerides in large LDL measurement | 1.47e-04 | 43 | 70 | 3 | EFO_0022319 | |
| Disease | cholesterol:total lipids ratio, intermediate density lipoprotein measurement | 2.00e-04 | 121 | 70 | 4 | EFO_0008595, EFO_0020943 | |
| Disease | systolic blood pressure, self reported educational attainment | 2.47e-04 | 10 | 70 | 2 | EFO_0004784, EFO_0006335 | |
| Disease | triglycerides in LDL measurement | 3.24e-04 | 56 | 70 | 3 | EFO_0022320 | |
| Disease | Anhedonia | 1.48e-03 | 24 | 70 | 2 | C0178417 | |
| Disease | fat body mass | 1.79e-03 | 217 | 70 | 4 | EFO_0005409 | |
| Disease | cholesteryl esters:total lipids ratio, intermediate density lipoprotein measurement | 1.91e-03 | 103 | 70 | 3 | EFO_0008595, EFO_0020944 | |
| Disease | C-reactive protein measurement | 2.14e-03 | 1206 | 70 | 9 | EFO_0004458 | |
| Disease | triglyceride measurement, intermediate density lipoprotein measurement | 2.36e-03 | 111 | 70 | 3 | EFO_0004530, EFO_0008595 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| AASSCKLRLWYHAAS | 136 | Q6UXC1 | |
| DVYTLETFAWCRSHS | 666 | Q8NDM7 | |
| WNTYPSTSCSSAALH | 396 | Q92685 | |
| EYQDSHSQQWSRCLS | 121 | Q9BZR8 | |
| AVSYSRLHSSDWNLC | 156 | Q96LT6 | |
| SASNLWLYTSRCRDA | 61 | Q9HCU4 | |
| FECSATSHASRLWQT | 61 | A6NI87 | |
| FHWSRCSQQELSRYL | 446 | O95450 | |
| NYARHWCSRLTDPNS | 616 | Q9HC84 | |
| YSATTHRWSPSCENL | 1286 | Q68CQ1 | |
| RSTYNHLSSWLTDAR | 96 | P61106 | |
| TLSCSSWSSYDIYHL | 241 | P43630 | |
| LSCRASQSVSSYLAW | 41 | A0A0A0MRZ8 | |
| SYTLEGNDLHWLACA | 76 | Q08999 | |
| DHRLNDSYSCLGWFS | 691 | Q9ULU8 | |
| TSAHYEENKSRWTCT | 321 | Q7L576 | |
| AHSSLDIASFYWTLT | 116 | Q8IV08 | |
| EDRWSSYCLSSLAAQ | 66 | Q96RG2 | |
| PCLQSASTWSSYEHN | 601 | A0AUZ9 | |
| DFYSHSNTLASTLRW | 281 | A6NCF5 | |
| HDCEWRCTSSFSYLN | 276 | Q9Y5Z7 | |
| KWLSSSNTSYCELCH | 96 | Q9P0N8 | |
| VAWQDYPCSSSHFRR | 81 | Q9NWZ8 | |
| TCRASQSIGSSLHWY | 41 | A0A0C4DH24 | |
| SSDWLVSAAHCVYGR | 816 | P98073 | |
| RLKHSRDWLCNSSYS | 1561 | Q15751 | |
| FYATNLSRTDLHSTW | 346 | O43526 | |
| TCRASQSIGSSLHWY | 41 | A0A0A0MT36 | |
| SASDYISDCWDSIFH | 516 | Q9Y2G8 | |
| LAYTISAIHQCSSWT | 121 | Q6AI08 | |
| TYDWTCFSHSLLNVS | 2031 | Q7Z7M0 | |
| STYLVWTCCLAHGAT | 511 | P49279 | |
| THAAIWAACISYLSA | 546 | Q6ZSS7 | |
| QLIDLGYLSSSHWNC | 306 | Q6XUX3 | |
| HPESCSYCRLSWASL | 331 | Q86T90 | |
| QAAYVDSSCWDSLLH | 76 | Q96QZ0 | |
| ASICSSAAIAWGRYH | 101 | P47804 | |
| HYCTRSQLAWNSAVS | 116 | P47804 | |
| NWTSLYTHVDDCSLN | 1176 | Q9ULT8 | |
| LNHSLEYTVAALSSW | 126 | O60725 | |
| SAARPSASAESHWCY | 11 | P22748 | |
| SNWRRLYSHLATDSV | 266 | Q4KMG0 | |
| ACSLHLSERADWQYS | 86 | Q6PCB6 | |
| DSDSLRHYSWAADTL | 956 | Q12955 | |
| DHRLNDSYSCLGWFS | 656 | Q86UW7 | |
| WSLTHSERYALQFAD | 41 | Q96BJ8 | |
| ETSWVTLDAAYHCTA | 81 | P21145 | |
| LEHWLSSSNTSYCEL | 101 | Q86UD3 | |
| WNRSSYRLHSNASES | 16 | P32245 | |
| TSTHFCASRYSDVWI | 211 | Q8NFN8 | |
| LSCRASQSVSSYLAW | 41 | P04433 | |
| SSFITHLDWAQDSSC | 506 | O95834 | |
| LSFITHLDWSSDSRY | 451 | Q05BV3 | |
| FRKNSSHWDHDYSCT | 6951 | Q8NDH2 | |
| ESPYCLLASHRTWSS | 411 | Q14746 | |
| VCWYRNTSVSRADHS | 911 | O94887 | |
| WLDQYNSSADTCTHA | 1266 | A3KN83 | |
| NSSADTCTHAYWRGN | 1271 | A3KN83 | |
| CSHYTQMVWASSNRL | 166 | Q9H3Y0 | |
| WSYDKTCSHRLSTAF | 691 | Q6UXH9 | |
| SICWADHLSDNYTLD | 11 | P10915 | |
| ASSLLTYDSWFLVHN | 636 | Q9UGT4 | |
| AFTCWINSQLARHTS | 36 | Q8WXH0 | |
| SYHSTFLLADRTEAW | 156 | Q96FV2 | |
| DLWHLSMRADSAYSS | 21 | Q2M3G4 | |
| SRCWYAALLSATALN | 191 | Q9NRX5 | |
| RLHCYASWRNSSGTI | 56 | Q13705 | |
| SANYSSPLWAAEHLC | 286 | Q9C0C6 | |
| CYQTQLSDWHTGLTD | 16 | Q9BYD5 | |
| HDTTSSAISWILYCL | 316 | Q86W10 | |
| IHSSWDCGLFTNYSA | 556 | Q8IU68 | |
| NDCGNTFRHWSSLVY | 766 | Q8N4W9 | |
| AIRSHCLTWTQYASM | 106 | Q8N945 | |
| CAYKTTASHEWSESS | 96 | Q6UX27 | |
| FWRTQHSCGNTYLSE | 171 | Q86WZ6 | |
| SYIWDSAQKTLHRCS | 181 | Q9H6R7 | |
| YRRAQHDDSLSWTSC | 176 | Q96NJ3 | |
| VTLPCLYSSWSHNSN | 36 | Q96H15 | |
| YWSDSTLHRISRANL | 1096 | O75096 |